At the heart of the Oncopole of Toulouse, the CRCT, together with all its partners (institutional, academic, clinical, industrial, charities…), stimulates innovation in terms of research and teaching in the fight against cancer.
The CRCT is a joint Research Unit Inserm & University Toulouse III Paul Sabatier
3 research teams are also labelled by the CNRS
Researchers, clinicians and supports
PhD students and post-doctoral fellows
Trabectedin is a cytotoxic drug used for the treatment of advanced soft tissue sarcoma. One of the most frequent side effects is hepatotoxicity, which occurs in nearly 40% of patients. In this pharmacogenetic study, we aimed to identify genetic polymorphisms that...
An international team , led by Dr Ludovic Martinet (Inserm researcher) and Pr Hervé Avet-Loiseau from the Toulouse Cancer Research Centre (CRCT / Inserm, University of Toulouse III - Paul Sabatier, CNRS), has just published a study in the journal Immunity which...
This year, the German Cancer Society (AEK) is presenting "the 5th AEK Autumn School" on the theme of "replicative stress and cancer". This Autumn School aims to promote exchanges between young scientists and experienced researchers in the field. In addition to...
Centre de Recherches en Cancérologie de Toulouse
2 avenue Hubert Curien
31037 TOULOUSE CEDEX 1 – FRANCE